Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04226742 · ClinicalTrials.gov registry record · NA
Evaluation of a Crowd-Powered Web Platform for Depression and Anxiety
A NA study, sponsored by University of California, Irvine.
- Completed
- Registry status
- NA
- Development phase
- 107
- Enrollment target
NCT04226742 is a NA study that has completed, run by University of California, Irvine. The registered enrollment target is 107 participants.
The verdict
NCT04226742, a NA study, has completed, sponsored by University of California, Irvine.
- COMPLETED
- Registry status
- NA
- Development phase
- 107 participants
- Enrollment target
Study Summary
100 participants will be enrolled in a two-armed randomized controlled trial of the Accumulated Depression and Anxiety Plans and Treatments (ADAPT) platform which integrates internet Cognitive Behavioral Therapy (iCBT) to determine impact on symptoms of depression and anxiety. This trial will pilot the effectiveness of the ADAPT platform, and evaluate the extent to which the ADAPT platform engages putative targets of personal relevance, skills use, and skills mastery.
Interventions
- BEHAVIORAL ADAPT Platform (Treatment)
- BEHAVIORAL ADAPT Comparison (Control)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 107 participants |
| Start Date | 2021-02-18 |
| Est. Completion | 2022-01-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04226742
The ClinicalTrials.gov registry entry for NCT04226742 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 107 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Irvine, which has 368 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which ADAPT Platform (Treatment) is the first listed.
NCT04226742 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04226742 about?
NCT04226742 is a clinical study titled "Evaluation of a Crowd-Powered Web Platform for Depression and Anxiety". 100 participants will be enrolled in a two-armed randomized controlled trial of the Accumulated Depression and Anxiety Plans and Treatments (ADAPT) platform which integrates internet Cognitive Behavioral Therapy (iCBT) to determine impact on symptoms of depression and anxiety. This trial will pilot ...
What is the current status of trial NCT04226742?
This trial is currently completed. It is a NA study. The enrollment target is 107 participants. The study started on 2021-02-18. Estimated completion is 2022-01-04.
What interventions are being tested in trial NCT04226742?
The interventions under investigation include: ADAPT Platform (Treatment) (BEHAVIORAL), ADAPT Comparison (Control) (BEHAVIORAL).
Who is sponsoring clinical trial NCT04226742?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.